424B5APRECIK 0001781983
Aprea Therapeutics, Inc.
Prospectus supplement (424B5) filed .
Prospectus supplement filed under Rule 424(b)(5) for a takedown from an existing shelf registration statement.
Filing facts
- Accession number
- 0001104659-24-115902
- Filer
- Aprea Therapeutics, Inc.
- Ticker
- APRE
- CIK
- 0001781983
- Form type
- 424B5
- Form description
- Prospectus supplement
- Filed at
- November 8, 2024
- Filing size
- 523.8 KB
- Last verified
- August 26, 2026SecFilingDex pulls from EDGAR with daily cadence
Provenance
Authoritative source — SEC EDGAR
https://www.sec.gov/Archives/edgar/data/1781983/000110465924115902/0001104659-24-115902-index.htm ↗Filer's full EDGAR submission history
EDGAR · Aprea Therapeutics, Inc. (0001781983) ↗Machine-readable JSON twin (LLM-citation friendly)
/api/filing/0001104659-24-115902.jsonSecFilingDex republishes SEC EDGAR data with provenance. EDGAR is the authoritative source. SecFilingDex is independent and not affiliated with the U.S. Securities and Exchange Commission. Nothing on this page constitutes investment, legal, tax, or other professional advice.